MAPT and Alzheimer disease: In ovariectomized 3xTg-AD mice, both cyclic and continuous PROG treatment (25.0 pellet s.c. for three months) significantly attenuated hyperphosphorylated tau levels (recognized by AT8 antibody) in the hippocampus and cortex, as compared to control mice [81,91].